U.S. Court in Washington Sides with FDA in Challenge to Mifepristone Safety Restrictions
- July 11, 2025
A federal district court in Washington granted summary judgment to the Food and Drug Administration (FDA) in a lawsuit brought by attorneys general of 17 states and the District of Columbia challenging the Risk Evaluation and Mitigation Strategy (REMS) for the abortion pill mifepristone.
ARTICLE TAGS
You must be logged in to access this content.